AIM Vaccine Co., Ltd.
AIM Vaccine Co., Ltd. (HKSE: 6660) is trading at HK$1.70, about ₹21 at today's HKD/INR rate, as of 25 Sep 2026, 3:49 AM ET, down 1.17% today. Indian residents can buy AIM Vaccine from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$1.70
Today's high
HK$1.82
52 week low
HK$1.20
52 week high
HK$4.48
6660 opened at HK$1.82, closed previously at HK$1.72, and has traded between HK$1.20 and HK$4.48 over the past 52 weeks.
About
Operating within the People's Republic of China, AIM Vaccine Co., Ltd. specializes in the entire lifecycle of human vaccine products, encompassing their discovery, production, and market introduction. Among its current developments, the company is advancing Bivalent Delta-Omicron BA.5 mRNA and Monovalent Omicron BA.5 mRNA vaccine candidates for COVID-19, both currently undergoing Phase III clinical trials. Its comprehensive portfolio also features vaccines targeting a range of other conditions, such as an EV71-CA16 Bivalent vaccine for Hand, Foot, and Mouth Disease (HFMD), and both Conjugate and Polysaccharide versions for pneumococcal disease. Further offerings include a Hexavalent group B Streptococcus Polysaccharide Conjugate Vaccine, various Diphtheria, Tetanus, and Pertussis (DTP) formulations (including DTP combined with Haemophilus Influenzae type B, acellular pertussis, and absorbed tetanus), a Haemophilus Influenzae Type B (Hib) vaccine, and both traditional freeze-dried and innovative mRNA human rabies vaccines. Beyond these, AIM Vaccine is actively developing several other vaccines, including 2- and 3-valent Human Papillomavirus (HPV) vaccines, a Tetravalent Meningococcal Conjugate vaccine, a Tetravalent Influenza vaccine, mRNA-based vaccines for Shingles/Herpes Zoster and Respiratory Syncytial Virus (RSV), a live attenuated parotitis vaccine, and an ACYW135 meningococcal polysaccharide vaccine. Established in 2011 and headquartered in Beijing, PRC, the company adopted its current name, AIM Vaccine Co., Ltd., in September 2020, having previously operated as Beijing AIM Biological Vaccine Technology Group Co., Ltd.
Key statistics
Avg. volume
520.98K
Market cap
HK$2.08B
P/E Ratio
-2.71
Price-to-sales ratio
1.78
Enterprise value
CN¥3.36B
Free cash flow yield
-5.39%
Debt-to-equity ratio
0.67
Return on equity
-24.66%
ROIC
-3.79%
Beta
0.10
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥1.15B
Earnings per share
-CN¥0.55
Free cash flow
-CN¥171.39M
Net profit margin
-66.76%
Gross margin
65.04%
EBITDA
-CN¥89.41M
Revenue growth
-10.17%
Similar securities
This is not an investment recommendation
How to buy AIM Vaccine from India
Indian residents can buy AIM Vaccine shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for AIM Vaccine and place an order
Find AIM Vaccine by name or by its ticker, 6660, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. AIM Vaccine trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your AIM Vaccine position in HKD and INR. AIM Vaccine pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in AIM Vaccine from India
Trading and taxes when buying AIM Vaccine from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneAIM Vaccine does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy AIM Vaccine stock?
Yes. AIM Vaccine (6660) has been listed on the Hong Kong Stock Exchange since 2022, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one AIM Vaccine share cost in rupees?
One AIM Vaccine share is HK$1.70 — about ₹21 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the AIM Vaccine price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying AIM Vaccine from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of AIM Vaccine?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on AIM Vaccine shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the AIM Vaccine price. Paasa issues a capital-gains statement for your return.
Does AIM Vaccine pay a dividend?
No. AIM Vaccine does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade AIM Vaccine from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is AIM Vaccine a Hong Kong SAR China company, and does that change how it is taxed?
AIM Vaccine trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. AIM Vaccine trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare AIM Vaccine shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your AIM Vaccine holding, its cost and its closing value.
How do I sell AIM Vaccine and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.